Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
MRKMerck & Co.
FinDog View：Neutral
| Metric | ABT | MRK |
|---|
| Close | 106.20 | 149.52 |
| Market Cap | $184B | $371B |
| 1M | +7.46% | +2.90% |
| P/E (TTM) | 39.1 | 117.2 |
| Forward P/E | 17.6 | 19.6 |
| P/E 5-Yr Percentile | 99 | 81 |
| P/S | 3.8 | 5.6 |
| P/B | 3.6 | 8.9 |
| Dividend Yield | 1.98% | 2.87% |
| Latest Quarter Revenue | $11.2B | $16.6B |
| Revenue YoY | +7.8% | +5.1% |
| Gross Margin | 56.2% | 73.5% |
| Latest Quarter EPS | 0.61 | -0.54 |
| Avg Post-Earnings Move | ±1.6% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 3.37% |
| 90-Day Net Insider Buying | −$46.9M | −$30.0M |
ABT · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
